|
|
| Quarterly Results |
|
| Beryl Drugs Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Sudhir Sethi | | Home : Indian Private | Book Value: 17.7338959 | | BSE Code : 524606 | Market Cap: 17.87 | | NSE Code : | P / E : 15.19 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 7.62 | 8.03 | 8.11 | 6.11 | | Other Income | 0.00 | 0.00 | 0.00 | 0.00 | | Total Income | 7.66 | 8.09 | 8.17 | 6.09 | | Total Expenditure | 6.86 | 7.37 | 7.04 | 5.82 | | Operating Profit | 0.80 | 0.72 | 1.13 | 0.27 | | Interest | 0.11 | 0.10 | 0.12 | 0.06 | | Gross Profit | 0.68 | 0.62 | 1.01 | 0.21 | | Depreciation | 0.31 | 0.29 | 0.28 | 0.15 | | Tax | 0.11 | 0.16 | 0.24 | 0.01 | | Deferred Tax | -0.05 | -0.10 | -0.04 | -0.02 | | Reported Profit After Tax | 0.31 | 0.27 | 0.53 | 0.06 |
|
|
|
|
|